- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2010
- Public Summary Document (PSD) November 2010 PBAC Meeting - PDF
Aztreonam – November 2010
Aztreonam, powder for inhalation, 75 mg (as lysine), with diluent, Cayston®
Last updated
21 March 2011